{"name":"Yu Wang","slug":"yu-wang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Donafeib with Sintilimab","genericName":"Donafeib with Sintilimab","slug":"donafeib-with-sintilimab","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Donafeib with Sintilimab","genericName":"Donafeib with Sintilimab","slug":"donafeib-with-sintilimab","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPNlRBMUxuQkF6VXV0TkhiLTlzSFFFeDQ3dFpacmNHYU5fX3dIQ084SFVKallRSGFONThGWEduc3N0aGFPVzUxZk1qOUJlLVZNcVVucGNfWVNEU2NPR1R4Wk0wMXZ3ME5ubWFjM3MtWmdqMHowSDZ2SkY0bnE0TkhLbW9BclNoeUxwRUJYTVZ0RDRHOXlnTWwtaTg3Y2RpVGdZYmtoajRTbHZqbFJjcHhhMmVGVG1JNms?oc=5","date":"2026-03-26","type":"pipeline","source":"UIC today","summary":"4 new UIC fellows of American Association for the Advancement of Science - UIC today","headline":"4 new UIC fellows of American Association for the Advancement of Science","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9Ldm5PaTEwaTBvVGpzc3E4WFNwMEZUS2VlelRPMUVUV25xaGlsWFVMcDRMeFRoQXRuUkhlc21RVmRsRDNhaVh5MTg1VHNtX18yNzh4RWpLTHZNdDl5cVhjNVBENHU2TUhvTHpOLS1tQXNENlV0WVNZSm81SkhLUQ?oc=5","date":"2025-12-18","type":"pipeline","source":"China Daily","summary":"China becomes key strategic market for CSL - China Daily","headline":"China becomes key strategic market for CSL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBSMWZoZVd5c29COF9Xa2pvOXh6YkVlNmx3bFhPb2pyS242T1FPcXUyWEtKY3pkai12Q3h6ZXRrcFhOQzAtYVBQb3lnSTdQMHRzNldZMHhsbG5nM2FtajNJ?oc=5","date":"2025-12-02","type":"pipeline","source":"Nature","summary":"Understanding interspecies drug response variations between human and rodent P2X7 receptors - Nature","headline":"Understanding interspecies drug response variations between human and rodent P2X7 receptors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPdWRULTZDdm5FZ1BQVG5jbHV5MzJJcXFHVFNoeEZLeENGdmIzS3FjYjQwdVdQdUViSzhxNkhXM19PQVcxT3lMck9pX3RRbldpMEtHRU9nT2RUVlVXMlB2RHp1aS14YkU3eWp0SlMwaU9CREtXU2YzUVR1NEFyNkhmUGVlZjZUUElaTW1HbTU3cW5DVW1IYTlmcmlyOUNuRGoxMHJIWUVaNF9QMTA?oc=5","date":"2025-10-20","type":"pipeline","source":"Deloitte","summary":"Deloitte China assists listing of Haixi Pharma on SEHK - Deloitte","headline":"Deloitte China assists listing of Haixi Pharma on SEHK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQZnF4NzlkMWdoY04wWUVpUENlNVdSU0s2MUJESzJRX2NQeVFpdDhJREhERVBOQU95eTllUV9UNU9WYmN4ZlR4T0FVY2VZN1ExZXpGTlg4bFVibmw2Z1lWMGNsbU9saE9QZWNIUXJqOFhMdFo1RWxUYUdpWVMtelFMQ19fWmVNd1VNWkVFajRFcXZKc0MxSVcxVW5ndW5YVkNYc05BNEVNeFdpdHhBMm56TklPYmFiUUNJMmE1SGZPRnpTRDVqcFdsckhQNA?oc=5","date":"2025-08-04","type":"trial","source":"BioPharma APAC","summary":"Luye Pharma Begins Phase 1 Trial of Novel Triple-Target Antidepressant LY03021 in China - BioPharma APAC","headline":"Luye Pharma Begins Phase 1 Trial of Novel Triple-Target Antidepressant LY03021 in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5nbUd6VmlaZTdLUUVRNkE3cENJOEpKTzhJbVM1dlh0cUFweGo1dElXc1JEN3Y1YjdhZWF4Slh4ZHRBNUJ5dEtGMU5xcnZiT1hKLTFFRmxISnVrZnQzNHAw?oc=5","date":"2025-05-19","type":"pipeline","source":"Nature","summary":"Intestinal permeability of N-acetylcysteine is driven by gut microbiota-dependent cysteine palmitoylation - Nature","headline":"Intestinal permeability of N-acetylcysteine is driven by gut microbiota-dependent cysteine palmitoylation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5HZXNoM01RWEc3VVZaMzVuUlB4amh0OVc0WGhvT2k5cUlOdlkzQ21UM0hqbkk2OFR6dVAyeUxMVW8zOHhJR3htektiNVVza1JrUXFJNzdvd3hwdkQ4bW5rdFJsdGdwdUNxQkFoSDBVeTZIamxEZFZJZTdVU0w1Zw?oc=5","date":"2025-05-11","type":"pipeline","source":"Yahoo Finance","summary":"Dr. Yuxin Chen, President and CEO of Jiangsu ProteLight Pharmaceutical & Biotechnology Co. Ltd., Honored as a 2025 Forbes China Pioneer Innovators in Industry Development - Yahoo Finance","headline":"Dr. Yuxin Chen, President and CEO of Jiangsu ProteLight Pharmaceutical & Biotechnology Co. Ltd., Honored as a 2025 Forbe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPVUxnYnI1QWc4eHNDUml4TXpCUUI3Ti1TLUhqTlpwVm5JOUF2SnhjMmlfS1cxYVEwa09FMi1kb3RuVzI5c1ZFaWVoXzdJRFN0dE02UF9DNC1jd2tsaXUzQTJLakE2VUxCX25JYXN1MktYM0FCcGNCREJSQVh0RkN4MUh6VzhWdnhwWG5jM182S21FTW1JVy15N3NUME9JVWFPZUlreA?oc=5","date":"2024-10-09","type":"pipeline","source":"Dao Insights","summary":"“Ill-timed” fashion show? Pfizer hosts event ahead of Shanghai Fashion Week - Dao Insights","headline":"“Ill-timed” fashion show? Pfizer hosts event ahead of Shanghai Fashion Week","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE00bTlSSHZDTE0ySmxaSTFPczY2V1ZDR2pycEE0eXd0V1lOSFhlZEpaSDNzazUwVS1wQmV3a2g3b1QwaGFoY1NqM3VVRnFFdndXLWpSRVFLOGpnM3drS2ZfZkZNQjRlc0dMa0ppOEhSOTUtWnVWYmc?oc=5","date":"2024-07-02","type":"pipeline","source":"Wiley","summary":"A NIR-II-Emissive Organic Nanomedicine with Biomimetic Engineering for High-Contrast Targeted Bioimaging and Multiple Phototherapies of Pancreatic Tumors - Wiley","headline":"A NIR-II-Emissive Organic Nanomedicine with Biomimetic Engineering for High-Contrast Targeted Bioimaging and Multiple Ph","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1tM3drSTJ4cXU0NTN4NGNfX3d0ZzV2RXFpeUVsbm83Q2hPcVNiN180YmtvMXFYT2VxVHhxLTVPSk16VWxrU09qN21KUXNhZ2FUSjNrVUQ1RWNqTjNXNmpwSUozWHItUEt1bGlhT1RuUDlnWkR6cEp1TWQtMA?oc=5","date":"2021-04-01","type":"earnings","source":"ScienceDirect.com","summary":"A new application of monosialotetrahexosylganglioside in pharmaceutics: preparation of freeze-thaw-resistant coenzyme Q10 emulsions - ScienceDirect.com","headline":"A new application of monosialotetrahexosylganglioside in pharmaceutics: preparation of freeze-thaw-resistant coenzyme Q1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNLVJGVkRrTy1Ld04yR1dpX002a3Q2VVZpUDFOdmZPUWFfTHVmQWE5Tlh6Ry1SYUVkcDJMT1doQkpMbzQ2YnRDS2ZYaW1HaWIyVEY4SXc2MGpmVGN4OUo3d2RKM2dMRUhHZDRhUGpoTjRHS2RzTFN6b3ZhdUE2ZU50ekxZYUlYdw?oc=5","date":"2020-12-01","type":"pipeline","source":"JD Corporate Blog","summary":"JDD Series: JD Health’s Intelligent Health Ecosystem - JD Corporate Blog","headline":"JDD Series: JD Health’s Intelligent Health Ecosystem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMjNxRDJvOGVUb1VzdHA5OGpVaENkMGU3N3NYU1BNZHAyMXNmNDhaY3UzY1pNMjV3R2IzeHFGOGdGUzYtZ0x2RmIxcTEyTTlsUVU4d3VSVE5rbDM1MHlOa0ZiR1owRDFiRXJ2RnRQcnV2MHZ6RGpOV0tLWnB2Ym1sMjN0OEtza1dsdGk0?oc=5","date":"2020-01-06","type":"pipeline","source":"Innovation News Network","summary":"New targets and novel biomarkers in cardiometabolic diseases - Innovation News Network","headline":"New targets and novel biomarkers in cardiometabolic diseases","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}